Last updated: 2026-09-21 01:54:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Sonoma Pharmaceuticals, Inc. (SNOA) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.29, with a market capitalization of $6.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.85 to $4.60. This page covers its latest market performance, valuation, price trends and company information.
$6.13M | |
$1.26 | |
$1,484.59 | |
$0.85 | |
$1.26 | |
60.77K | |
130.06K | |
-- | |
$4.60 | |
$0.85 | |
-- | |
-- |
Sonoma Pharmaceuticals, Inc. (SNOA) last closed at $1.26 as of 2026-09-18 22:26:00, unchanged from the previous close of $1.26.
During the latest regular trading session, SNOA traded between $0.85 and $1,484.59, with a volume of 60.77K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Sonoma Pharmaceuticals, Inc. (SNOA) moved from $1.31 to $1.29, representing a decline of 1.91% ($0.03).
The stock traded between $1.23 and $1.34 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 58.82 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 11.6%
SNOA is currently trading at $1.29, placing it 11.6% of the way from its 52-week low of $0.85 to its 52-week high of $4.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 260 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sonoma Pharmaceuticals, Inc. (SNOA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.